Pediatric Perfusion Products Market Share

North America industry is predicted to hold largest revenue share by 2037, on account of high prevalence of congenital heart diseases in the U.S., increase in diagnosis rate of congenital heart diseases, high open heart surgery rate, and well-established health care infrastructure.

According to the Centers for Disease Control and Prevention (CDC), congenital heart diseases affect approximately 1% of the total pediatric population in the U.S. every year. The widespread presence of mild congenital heart diseases has increased in the country in the past five years, whereas the prevalence of critical congenital heart diseases has been stable.

Germany, the U.K., and France held the major shares of the pediatric perfusion market in Europe for the year 2018. This can be attributed to high rate of diagnosis and treatment of congenital heart diseases, highly developed health care industry, presence of ambulatory surgery centers and availability of sophisticated instruments in hospitals.

China and Japan attained dominant shares of the market in the Asia Pacific region in 2018 owing to growing patient population, and soaring investments in research & development ventures by healthcare organisations. The market in India is estimated to expand at high growth in the next few years, owing to a large population of neonates and developing health care infrastructure. However, underdeveloped health care infrastructure and unavailability of skilled pediatric heart surgeons are some of the factors that might negatively affect the growth of the pediatric perfusion market in Latin America, the Middle East & Africa during the forecast period.